Detecting role of apoptosis in mediating cyclophosphamide induced teratogenesis in vitro

Toxicology Mechanisms and Methods

Volumn 15, Issue 6, 2005, Pages 391-397

  Singh, Gyanendra ^a   Sinha, Neeraj ^a   Jayendra Koushik, C ^b   Mathur, S K ^a   Srivastava, Sudhir ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Apoptosis; Cyclophosphamide; Embryo culture; In vitro

Indexed keywords

CYCLOPHOSPHAMIDE; DNA FRAGMENT; LIPOCORTIN 5;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL LABELING; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; FEMALE; FLOW CYTOMETRY; GROWTH RETARDATION; MALFORMATION SYNDROME; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TERATOGENICITY;

ANIMALIA;

EID: 30744474189     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376520500194791     Document Type: Article

References (28)

1. Arends, M. J., and Wyllie, A. M. 1991. Apoptosis mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32:233-254.
2. Arends, M. J., Morris, R. J., and Wyllie, A. H. 1990. Apoptosis: The role of the endonuclease. Am J. Pathol. 136:593-608.
3. Chernoff, N., Roger, J. M., Alles, A. J., Zucker, R. M., Elstein, K. M., Massaro, E. S., and Sulik, K. C., 1989. Cell cycle alterationa and cell death in cyclophosphamide teratogenisis. Teratogenisis Carcino. Mutagen. 9:199-209.
4. Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T., and Traganos, F. 1997. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1-20.
5. Del Bino, G., Darzynkiewicz, Z., Degraef, C., Mosselmans, R., Fokan, D., and Galand, P., 1999. Comparison of methods based on annexin-V binding. DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells. Cell Proliferation 32:25-37.
6. Greenaway, J. C., Fantal, A. G., Shephard, T. J., and Juchau M. R. 1982. The in vivo teratogenicity of cyclophosphamide on rat embryos. Teratol. 25:335-343.
7. Gold, R., Schmied, M., Giegrich, G., Breitchopf, H., Hartung, H. P., Toyka, K.V., and Laumann, H 1994. Differentiation between cellular apoptosis and necrosis by the combined use of insitu tailing and nick translation techniques. Lab. Invest. 71-219.
8. Gomez-Lechon, M. J., O-Connor, E., Castell, J. V., and Jover, R. 2002. Sensitive markers used to identify compounds that trigger apoptosis in cultured hepatocytes. Toxicol Sciences. 65:299-308.
9. Hales, B. F. 1989. Effect of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphomide, on mouse limb development in vitro. Teratol. 40:1-20.
10. Huitema, A. D. R., Smits, K. D., Mathot, R. A., Schellens, J. H. M., and Rodenhuis, S. 2000. The clinical pharmacology of alkylating agents in high-dose chemotherapy. Anti-Cancer Drugs. 11:515-533.
11. Kerr, J. F. R. 1971. Shrinkage necrosis: A distinct mode of cellular death. J. Pathol. 105:13-20.
12. Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. 1972. Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Br. J. Pathol. 26:239-245.
13. Lee, S. P., Park, H. W., Thayer, J., Mirkes, P. E., and Juchau, M. R. 1996. Apoptosis induced in cultured rat embryos by intra-amniotically microinjected sodium nitropruside. Teratol. 53:21-30.
14. Lennon, S. V., Martin, S. J., and Cotter, T. G. 1991. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Proliferation 24:203-214.
15. Little, S. A., and Mirks, P. E. 1987. DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroxy cyclophosphamide and phisphaoramide in postimplantation rat embryos. Cancer Res. 47:5421-5426.
16. Little, S. A., and Mirkes, P. E. 1990. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos. Teratol. 41:233-231.
17. Matalon, S. T., Ornoy, A., and Lishner, M. 2004. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprime, doxorubicin on the embryo and placenta). Reprod. Toxicol. 18:219-230.
18. Mirks, P. E. 1985. Cyclophosphamide teratogenisis - a review. Teratogenisis Carcinog. Mutagen. 5:75-88.
19. Mundle, S. D., and Raza, A. 1995. Correspondence: The two in-situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of fragmentation in apoptosis. Lab. Invest. 72:611.
20. New, D. A. T. 1978. Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev. 53:81-122.
21. Slott, V. L., and Hales, B. F. 1987. Enhancement of the embryotoxicity of acrolein, but not phosphoramide mustard, by glutathione depletion in rat embryos in vitro. Biochem. Pharmacol. 36:2019-2025.
22. Singh, G., Sinha, N., Sharma, S., and Srivastava, S. 2004a. Histological changes due to in vitro exposure of cyclophosphamide in post implantation rat embryos. Indian J. Vet. Pathol. 5:24-28.
23. Singh, G., Sinha, N., Kaushik, C. J., Srivastava, S., and Mathur, S. K. 2004b. Assessing teratogenicity of cyclophosphamide by using rat whole embryo culture. J. Lab. Med. (manuscript in press).
24. Slott, V. L., and Hales, B. F. 1988. Role of 4-hydroxy intermediates in the in vivo embryotoxicity of cyclophosphamide and dechlorocyclophosphamide. Toxicol. Appl. Pharmacol. 92:170-178.
25. Thompson, C. B. 1995. Apoptosis in the pathogenesis & treatment of diseases. Scinece. 267:1459-1462.
26. Tilly, J. L., and Hsuch, A. J. W. 1993. Microsomal autoratiographic methods for the quantitative & qualitative analysis of apoptotic DNA fragmentation. J. Cell. Physiol. 154:519-526.
27. Wyllie, A. H. 1980. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.
28. Yu, L. J., Drewes, P., Gustafsson, K., Hecht, J. E. D., and Waxman, D. J. 1999. In vivo modulation of alternative pathways of P-450 catalyzed cyclophosphamide metabolism: Impact on pharmacokinetics and antitumor activity. J. Pharmacol. Exp. Ther. 288:928-937.